European Archives - Page 374 of 1133 - European Medical Journal

Sarcomas Unveiled: Advances in Rare Cancer Care

Brian Van Tine joins Jonathan to provide an overview of his clinical interest in soft tissue and bone sarcomas.

Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review

This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…

The Enduring Potential of Anti-TNF Therapies: Insights from UEG Week 2023

This News Feature explores the approaches for optimising anti-TNF therapies in gastroenterology, based on content delivered during UEG…

Editor's Pick: Chrono-nutrition and Type 2 Diabetes

Type 2 diabetes (T2D) is a persistent metabolic anarchy, described by hyperglycaemia resulting from defects in insulin secretion…

Use of Artificial Intelligence Improves Outcomes in Intracranial Haemorrhage

Researchers found that the rapid growth of AI use in healthcare and its improving ability in prioritising and triaging suspected findings leads to early therapeutic interventions, particularly in ICH cases.

Time to trade in the traditional marketing model?

The evolution of customer engagement in pharmaceutical industry according to Rick Hollis, Director of Business Excellence, Ipsen. Listen now!

Interview: Pia Leete

A career in research had never been something I had considered, and I came to it quite late: having had quite an itinerant youth…

Associations Between Sleep Duration and Brain Volume in Hispanic Populations

A recent research conducted in the USA suggests that longer sleep duration might be associated with lower total brain and grey matter volume in a study of Hispanic and Latino individuals.

EMJ Respiratory 11.1 2023 cover

EMJ Respiratory 11.1 2023

Our latest issue of EMJ Respiratory includes an insightful feature on high-flow nasal cannula oxygen therapy and an exclusive interview…

Balancing Patient Outcomes and Environmental Sustainability in Respiratory Care

This ERS International Congress 2023 review considers prioritising patient outcomes to ensure access to essential inhaled medicines when considering the carbon footprint of inhalers.